XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
US Stock MarketDetailed Quotes
MDWD MediWound
- 18.760
- +0.140+0.75%
Close Feb 14 16:00 ET
- 18.760
- 0.0000.00%
Post 16:01 ET
202.42MMarket Cap-6.45P/E (TTM)
19.200High18.310Low48.87KVolume18.670Open18.620Pre Close922.24KTurnover0.65%Turnover RatioLossP/E (Static)10.79MShares24.00052wk High5.91P/B140.08MFloat Cap12.78052wk Low--Dividend TTM7.47MShs Float135.170Historical High--Div YieldTTM4.78%Amplitude7.100Historical Low18.871Avg Price1Lot Size
Trending Stocks
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve
Moo Earnings
Feb 2 12:39
AMZN earnings preview: Grab rewards by guessing the opening price!
MediWound Stock Forum
MediWound to Host Virtual Key Opinion Leader Event to Discuss EscharEx® Phase III VALUE Study in Venous Leg Ulcers and Its Commercial Opportunity on January 8, 2025
Tuesday, 17th December at 8:00 am
YAVNE, Israel, Dec. 17, 2024 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced it will host a virtual Key Opinion Leader (KOL) event on Wednesday, January 8, 2025, at 10:00 AM ET. T...
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet